# XACT Norden (UCITS ETF) (0G34)

**Source:** https://fundology.uk/fund/0g34 · ISIN SE0001710914 · Data: TradingView (LSE closes and returns, delayed), issuer documents, ONS CPIH, FCA FIRDS

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 30/09/2026, 0G34 (XACT Norden (UCITS ETF), ISIN SE0001710914) closed at SEK 300.55 on the London Stock Exchange. Its ongoing charge is 0.15% a year (about £15 on £10,000).

## Summary

XACT Norden (UCITS ETF) is an exchange-traded fund (ETF) from XACT, launched in 2006. It tracks the Solactive ISS ESG Screened Nordic 50 Index - SEK - Benchmark TR Net. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.15% a year — about £15 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

Latest close: **SEK 300.55** (30/09/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | 0G34 |
| ISIN | SE0001710914 |
| Category | European shares |
| Type | ETF |
| Provider | XACT |
| Tracks | Solactive ISS ESG Screened Nordic 50 Index - SEK - Benchmark TR Net |
| Income | Accumulating |
| Ongoing charge | 0.15% a year (£15 per £10,000) |
| Fund size | £84.0m |
| Launched | 2006 |
| Domicile | Sweden |

## Charges compared with similar funds

Ongoing charge of XACT Norden (UCITS ETF) 0.15% a year, as of 01/10/2026: 152 of the 225 other European share funds charge more, 14 the same and 59 less (share classes counted once).

## Charges & eligibility

- Ongoing charges figure (OCF): **0.15%** per year
- ISA eligible: yes
- SIPP eligible: yes

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.